Research progress on liver transplantation for benign liver tumors

Ni Yuanzhi; Zhang Wu

doi:10.3969/j.issn.1674-7445.2022.06.008

Volume 13 Issue 6

Nov. 2022

Turn off MathJax

Article Contents

Article Navigation > ORGAN TRANSPLANTATION > 2022 > 13(6): 742-748

Ni Yuanzhi, Zhang Wu. Research progress on liver transplantation for benign liver tumors[J]. ORGAN TRANSPLANTATION, 2022, 13(6): 742-748. doi: 10.3969/j.issn.1674-7445.2022.06.008

Citation:

Ni Yuanzhi, Zhang Wu. Research progress on liver transplantation for benign liver tumors[J]. ORGAN TRANSPLANTATION, 2022, 13(6): 742-748. doi: 10.3969/j.issn.1674-7445.2022.06.008

Citation:

Ni Yuanzhi, Zhang Wu. Research progress on liver transplantation for benign liver tumors[J]. ORGAN TRANSPLANTATION, 2022, 13(6): 742-748. doi: 10.3969/j.issn.1674-7445.2022.06.008

PDF( 984 KB)

Research progress on liver transplantation for benign liver tumors

doi: 10.3969/j.issn.1674-7445.2022.06.008

Ni Yuanzhi,
Zhang Wu^,

School of Medicine, Zhejiang University, Hangzhou 310000, China

More Information

Corresponding author: Zhang Wu, Email: wu.zhang@shulan.com
Received Date: 2022-05-26
Available Online: 2022-11-14
Publish Date: 2022-11-15

Abstract

Abstract

Liver tumors can be divided into benign and malignant types. Benign liver tumors are relatively common, which are mainly treated with follow-up observation and interventional therapy, and surgical resection should be performed for few cases. Liver transplantation can effectively treat end-stage liver diseases, whereas it is seldom applied in the treatment of benign liver tumors. Liver transplantation is only considered for benign liver tumors with huge space-occupying compression, liver failure, the risk of tumor rupture and bleeding or malignant transformation. Compared with malignant tumors and chronic liver failure, liver transplantation yields an equivalent risk for benign liver tumors, favorable clinical prognosis and long-term survival. However, comprehensive evaluation should be delivered before liver transplantation for benign liver tumors, and extensive attention should be paid to the difficulty of donor liver matching in the new situation. In this article, research progress on liver transplantation for benign liver tumors including hepatic hemangioma, polycystic liver, hepatocellular adenoma, hepatic mesenchymal hamartoma was reviewed, aiming to provide reference for liver transplantation in the treatment of benign liver tumors.
- Benign liver tumor,
- Liver transplantation,
- Hepatic hemangioma,
- Polycystic liver,
- Hepatocellular adenoma,
- Hepatic mesenchymal hamartoma,
- Space-occupying compression,
- Rupture bleeding

FullText(HTML)

References(57)

References

[1]	AEHLING NF, SEEHOFER D, BERG T. Liver transplantation-current trends[J]. Dtsch Med Wochenschr, 2020, 145(16): 1124-1131. DOI: 10.1055/a-0982-0737.
[2]	国际肝胆胰协会中国分会肝血管瘤专业委员会. 肝血管瘤诊断和治疗多学科专家共识(2019版)[J]. 中华消化外科杂志, 2019, 18(8): 705-710. DOI: 10.3760/cma.j.issn.1673-9752.2019.08.001. Professional Committee of Hepatobiliary Hemangioma, Chinese Branch of the International Hepatobiliary and Pancreatic Association. Multidisciplinary expert consensus on the diagnosis and treatment of hepatic hemangioma (2019 edition)[J]. Chin J Dig Surg, 2019, 18(8): 705-710. DOI: 10.3760/cma.j.issn.1673-9752.2019.08.001.
[3]	TELLI TA, OKTEN IN, TUYLU TB, et al. VEGF-VEGFR pathway seems to be the best target in hepatic epithelioid hemangioendothelioma: a case series with review of the literature[J]. Curr Probl Cancer, 2020, 44(5): 100568. DOI: 10.1016/j.currproblcancer.2020.100568.
[4]	SAKAMOTO Y, KOKUDO N, WATADANI T, et al. Proposal of size-based surgical indication criteria for liver hemangioma based on a nationwide survey in Japan[J]. J Hepatobiliary Pancreat Sci, 2017, 24(7): 417-425. DOI: 10.1002/jhbp.464.
[5]	EGHLIMI H, ARASTEH P, AZADE N. Orthotopic liver transplantation for management of a giant liver hemangioma: a case report and review of literature[J]. BMC Surg, 2020, 20(1): 142. DOI: 10.1186/s12893-020-00801-z.
[6]	王连江, 张雅敏, 邓永林, 等. 肝移植治疗肝脏良性肿瘤六例临床分析[J]. 中华医学杂志, 2016, 96(26): 2091-2093. DOI: 10.3760/cma.j.issn.0376-2491.2016.26.011. WANG LJ, ZHANG YM, DENG YL, et al. Liver transplantation for benign liver tumor: six cases report and literature review[J]. Natl Med J China, 2016, 96(26): 2091-2093. DOI: 10.3760/cma.j.issn.0376-2491.2016.26.011.
[7]	LI T, KLAR MM, ALAWAD M, et al. Hepatic sclerosing hemangioma mimicking malignancy: a case and literature review[J]. Am J Med Case Rep, 2021, 9(3): 144-146. DOI: 10.12691/ajmcr-9-3-2.
[8]	UNAL E, FRANCIS F, AQUINO A, et al. Liver transplant for mixed capillary-cavernous hemangioma masquerading as hepatocellular carcinoma in a patient with hepatocellular carcinoma[J]. Exp Clin Transplant, 2011, 9(5): 344-348.
[9]	SOOD D, MOHAN N, SINGH A, et al. Living donor liver transplantation for giant cavernous hemangioma of liver in a child[J]. Pediatr Transplant, 2011, 15(7): E135-E138. DOI: 10.1111/j.1399-3046.2010.01320.x.
[10]	WANG Y, ZHOU Y, MIAO L. Pulmonary capillary hemangioma-like pulmonary artery hypertension associated with interferon-alpha therapy[J]. Am J Ther, 2020, 27(5): e511-e514. DOI: 10.1097/MJT.0000000000001141.
[11]	JI Y, CHEN S, YANG K, et al. Kaposiform hemangioendothelioma: current knowledge and future perspectives[J]. Orphanet J Rare Dis, 2020, 15(1): 39. DOI: 10.1186/s13023-020-1320-1.
[12]	VAGEFI PA, KLEIN I, GELB B, et al. Emergent orthotopic liver transplantation for hemorrhage from a giant cavernous hepatic hemangioma: case report and review[J]. J Gastrointest Surg, 2011, 15(1): 209-214. DOI: 10.1007/s11605-010-1248-1.
[13]	叶伯根, 朱红飞, 殷鹏, 等. 肝移植治疗肝脏巨大血管瘤和多囊肝三例临床分析[J/CD]. 中华移植杂志(电子版), 2020, 14(4): 241-244. DOI: 10.3877/cma.j.issn.1674-3903.2020.04.010. YE BG, ZHU HF, YIN P, et al. Liver transplantation for liver giant haemangioma and polycystic liver disease[J/CD]. Chin J Transplant (Electr Edit), 2020, 14(4): 241-244. DOI: 10.3877/cma.j.issn.1674-3903.2020.04.010.
[14]	KLOMPMAKER IJ, SLOOF MJ, VAN DER MEER J, et al. Orthotopic liver transplantation in a patient with a giant cavernous hemangioma of the liver and Kasabach-Merritt syndrome[J]. Transplantation, 1989, 48(1): 149-151. DOI: 10.1097/00007890-198907000-00035.
[15]	MORA A, CORTÉS C, ROIGÉ J, et al. Orthotopic liver transplant for giant cavernous hemangioma and Kasabach-Merritt syndrome[J]. Rev Esp Anestesiol Reanim, 1995, 42(2): 71-74.
[16]	TEPETES K, SELBY R, WEBB M, et al. Orthotopic liver transplantation for benign hepatic neoplasms[J]. Arch Surg, 1995, 130(2): 153-156. DOI: 10.1001/archsurg.1995.01430020043005.
[17]	BROUWERS MA, PEETERS PM, DE JONG KP, et al. Surgical treatment of giant haemangioma of the liver[J]. Br J Surg, 1997, 84(3): 314-316.
[18]	CHUI AK, VASS J, MCCAUGHAN GW, et al. Giant cavernous haemangioma: a rare indication for liver transplantation[J]. Aust N Z J Surg, 1996, 66(2): 122-124. DOI: 10.1111/j.1445-2197.1996.tb01132.x.
[19]	LONGEVILLE JH, DE LA HALL P, DOLAN P, et al. Treatment of a giant haemangioma of the liver with Kasabach-Merritt syndrome by orthotopic liver transplant a case report[J]. HPB Surg, 1997, 10(3): 159-162. DOI: 10.1155/1997/10136.
[20]	RUSSO MW, JOHNSON MW, FAIR JH, et al. Orthotopic liver transplantation for giant hepatic hemangioma[J]. Am J Gastroenterol, 1997, 92(10): 1940-1941.
[21]	KUMASHIRO Y, KASAHARA M, NOMOTO K, et al. Living donor liver transplantation for giant hepatic hemangioma with Kasabach-Merritt syndrome with a posterior segment graft[J]. Liver Transpl, 2002, 8(8): 721-724. DOI: 10.1053/jlts.2002.33689.
[22]	FERRAZ AA, SETTE MJ, MAIA M, et al. Liver transplant for the treatment of giant hepatic hemangioma[J]. Liver Transpl, 2004, 10(11): 1436-1437. DOI: 10.1002/lt.20250.
[23]	MEGURO M, SOEJIMA Y, TAKETOMI A, et al. Living donor liver transplantation in a patient with giant hepatic hemangioma complicated by Kasabach-Merritt syndrome: report of a case[J]. Surg Today, 2008, 38(5): 463-468. DOI: 10.1007/s00595-007-3623-4.
[24]	ZHONG L, MEN TY, YANG GD, et al. Case report: living donor liver transplantation for giant hepatic hemangioma using a right lobe graft without the middle hepatic vein[J]. World J Surg Oncol, 2014, 12: 83. DOI: 10.1186/1477-7819-12-83.
[25]	LANGE UG, BUCHER JN, SCHOENBERG MB, et al. Orthotopic liver transplantation for giant liver haemangioma: a case report[J]. World J Transplant, 2015, 5(4): 354-359. DOI: 10.5500/wjt.v5.i4.354.
[26]	LEE JH, YOON CJ, KIM YH, et al. Living-donor liver transplantation for giant hepatic hemangioma with diffuse hemangiomatosis in an adult: a case report[J]. Clin Mol Hepatol, 2018, 24(2): 163-168. DOI: 10.3350/cmh.2017.0002.
[27]	MASYUK TV, MASYUK AI, LARUSSO NF. Polycystic liver disease: advances in understanding and treatment[J]. Annu Rev Pathol, 2022, 17: 251-269. DOI: 10.1146/annurev-pathol-042320-121247.
[28]	BARTEN TRM, BERNTS LHP, DRENTH JPH, et al. New insights into targeting hepatic cystogenesis in autosomal dominant polycystic liver and kidney disease[J]. Expert Opin Ther Targets, 2020, 24(6): 589-599. DOI: 10.1080/14728222.2020.1751818.
[29]	ZHANG ZY, WANG ZM, HUANG Y. Polycystic liver disease: classification, diagnosis, treatment process, and clinical management[J]. World J Hepatol, 2020, 12(3): 72-83. DOI: 10.4254/wjh.v12.i3.72.
[30]	DOSHI SD, BITTERMANN T, SCHIANO TD, et al. Waitlisted candidates with polycystic liver disease are more likely to be transplanted than those with chronic liver failure[J]. Transplantation, 2017, 101(8): 1838-1844. DOI: 10.1097/TP.0000000000001711.
[31]	DRENTH JP, CHRISPIJN M, NAGORNEY DM, et al. Medical and surgical treatment options for polycystic liver disease[J]. Hepatology, 2010, 52(6): 2223-2230. DOI: 10.1002/hep.24036.
[32]	RODRÍGUEZ-AGUILAR EF, SASTRE L, COLMENERO J, et al. Liver and kidney transplantation in polycystic liver and kidney disease[J]. Gastroenterol Hepatol, 2021, 44(8): 552-558. DOI: 10.1016/j.gastrohep.2020.12.004.
[33]	VAN KEIMPEMA L, NEVENS F, ADAM R, et al. Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study[J]. Transpl Int, 2011, 24(12): 1239-1245. DOI: 10.1111/j.1432-2277.2011.01360.x.
[34]	DING F, TANG H, ZHAO H, et al. Long-term results of liver transplantation for polycystic liver disease: single-center experience in China[J]. Exp Ther Med, 2019, 17(5): 4183-4189. DOI: 10.3892/etm.2019.7449.
[35]	COQUILLARD C, BERGER J, DAILY M, et al. Combined liver-kidney transplantation for polycystic liver and kidney disease: analysis from the United Network for Organ Sharing dataset[J]. Liver Int, 2016, 36(7): 1018-1025. DOI: 10.1111/liv.13041.
[36]	ALSAGER M, NEONG SF, GANDHI R, et al. Liver transplantation in adult polycystic liver disease: the Ontario experience[J]. BMC Gastroenterol, 2021, 21(1): 115. DOI: 10.1186/s12876-021-01703-x.
[37]	MOORS G, POELS H, VANDECAVEYE V, et al. Regression of multiple hepatocellular adenomas after cessation of oral contraceptive pills: a case report and review of the current literature[J]. Acta Gastroenterol Belg, 2021, 84(3): 505-508. DOI: 10.51821/84.3.017.
[38]	OUDMAIJER CAJ, BERK KA, VAN DER LOUW EJTM, et al. KETOgenic diet therapy in patients with HEPatocellular adenoma: study protocol of a matched interventional cohort study[J]. BMJ Open, 2022, 12(2): e053559. DOI: 10.1136/bmjopen-2021-053559.
[39]	KRAUSE K, TANABE KK. A shifting paradigm in diagnosis and management of hepatic adenoma[J]. Ann Surg Oncol, 2020, 27(9): 3330-3338. DOI: 10.1245/s10434-020-08580-w.
[40]	ZHENG J, SADOT E, VIGIDAL JA, et al. Characterization of hepatocellular adenoma and carcinoma using microRNA profiling and targeted gene sequencing[J]. PLoS One, 2018, 13(7): e0200776. DOI: 10.1371/journal.pone.0200776.
[41]	JULIEN C, LE BAIL B, CHICHE L, et al. Malignant transformation of hepatocellular adenoma[J]. JHEP Rep, 2022, 4(3): 100430. DOI: 10.1016/j.jhepr.2022.100430.
[42]	HUANG WC, LIAU JY, JENG YM, et al. Hepatocellular adenoma in Taiwan: distinct ensemble of male predominance, overweight/obesity, and inflammatory subtype[J]. J Gastroenterol Hepatol, 2020, 35(4): 680-688. DOI: 10.1111/jgh.14903.
[43]	FONSECA EA, FEIER F, VINCENZI R, et al. Living donor liver transplantation as a backup procedure: treatment strategy for hepatocellular adenomas requiring complex resections[J]. Case Rep Surg, 2022: 1015061. DOI: 10.1155/2022/1015061.
[44]	SANTAMBROGIO R, MARCONI AM, CERETTI AP, et al. Liver transplantation for spontaneous intrapartum rupture of a hepatic adenoma[J]. Obstet Gynecol, 2009, 113(2 Pt 2): 508-510. DOI: 10.1097/AOG.0b013e318187ff42.
[45]	MARTINS-FILHO SN, PUTRA J. Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review[J]. Hepat Oncol, 2020, 7(2): HEP19. DOI: 10.2217/hep-2020-0002.
[46]	LI J, CAI JZ, GUO QJ, et al. Liver transplantation for a giant mesenchymal hamartoma of the liver in an adult: case report and review of the literature[J]. World J Gastroenterol, 2015, 21(20): 6409-6416. DOI: 10.3748/wjg.v21.i20.6409.
[47]	HERNÁNDEZ JC, ALFONSO C, GONZÁLEZ L, et al. Solid mesenchymal hamartoma in an adult: a case report[J]. J Clin Pathol, 2006, 59(5): 542-545. DOI: 10.1136/jcp.2004.024398.
[48]	PAN ET, YOELI D, KUEHT ML, et al. Liver transplantation as definitive treatment of an unresectable mesenchymal hamartoma in a child with Beckwith-Wiedemann syndrome[J]. J Surg Case Rep, 2017(8): rjx167. DOI: 10.1093/jscr/rjx167.
[49]	WANG KH, KUPA J, DUFFY KA, et al. Diagnosis and management of Beckwith-Wiedemann syndrome[J]. Front Pediatr, 2020, 7: 562. DOI: 10.3389/fped.2019.00562.
[50]	KLOMPENHOUWER AJ, VERVER D, JANKI S, et al. Management of hepatic angiomyolipoma: a systematic review[J]. Liver Int, 2017, 37(9): 1272-1280. DOI: 10.1111/liv.13381.
[51]	YANG G, HWANG S, AHN CS, et al. Clinicopathological correlation and post-resection outcomes of hepatic angiomyolipoma[J]. Ann Hepatobiliary Pancreat Surg, 2021, 25(2): 215-220. DOI: 10.14701/ahbps.2021.25.2.215.
[52]	KLOMPENHOUWER AJ, DWARKASING RS, DOUKAS M, et al. Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome[J]. HPB (Oxford), 2020, 22(4): 622-629. DOI: 10.1016/j.hpb.2019.09.004.
[53]	STEINBORN JK, RAWITZER J, GALLINAT A, et al. Angiomyolipoma of the liver-a case report and review of the literature[J]. Pathologe, 2020, 41(6): 643-648. DOI: 10.1007/s00292-020-00834-4.
[54]	DUMORTIER J, GUILLAUD O, WALTER T, et al. Liver transplantation for multiple angiomyolipomas complicating tuberous sclerosis complex[J]. Gastroenterol Clin Biol, 2010, 34(8/9): 494-498. DOI: 10.1016/j.gcb.2010.06.005.
[55]	WANG WT, LI ZQ, ZHANG GH, et al. Liver transplantation for recurrent posthepatectomy malignant hepatic angiomyolipoma: a case report[J]. World J Gastroenterol, 2015, 21(12): 3755-3758. DOI: 10.3748/wjg.v21.i12.3755.
[56]	BRAHMBHATT M, PRENNER S, BITTERMANN T. Liver transplantation for hepatic epithelioid hemangioendothelioma is facilitated by exception points with acceptable long-term outcomes[J]. Transplantation, 2020, 104(6): 1187-1192. DOI: 10.1097/TP.0000000000002982.
[57]	LAI Q, FEYS E, KARAM V, et al. Hepatic epithelioid hemangioendothelioma and adult liver transplantation: proposal for a prognostic score based on the analysis of the ELTR-ELITA Registry[J]. Transplantation, 2017, 101(3): 555-564. DOI: 10.1097/TP.0000000000001603.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1)

Get Citation

PDF

XML

Article Metrics

Article views (264) PDF downloads(79)

Research progress on liver transplantation for benign liver tumors

doi: 10.3969/j.issn.1674-7445.2022.06.008

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Research progress on liver transplantation for benign liver tumors

doi: 10.3969/j.issn.1674-7445.2022.06.008

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content